RAISED SERUM CA-125 PRECEDING THE DIAGNOSIS OF CARCINOMA OF THE FALLOPIAN-TUBE - 2 CASE-REPORTS

被引:11
|
作者
DAVIES, AP
FISH, A
WOOLAS, R
ORAM, D
机构
[1] Department of Obstetrics and Gynaecology, The London Hospital, London, E1 1BB, Whitechapel
来源
关键词
D O I
10.1111/j.1471-0528.1991.tb10381.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:602 / 603
页数:2
相关论文
共 36 条
  • [31] ELEVATED SERUM CA-19-9 LEVELS IN HEPATOBILIARY CYSTADENOMA WITH MESENCHYMAL STROMA - 2 CASE-REPORTS WITH IMMUNOHISTOCHEMICAL CONFIRMATION
    THOMAS, JA
    SCRIVEN, MW
    PUNTIS, MCA
    JASANI, B
    WILLIAMS, GT
    CANCER, 1992, 70 (07) : 1841 - 1846
  • [32] DIAGNOSIS AND TREATMENT OF VULVAR CARCINOMA INSITU WITH ANAL INVOLVEMENT IN YOUNG-WOMEN - 2 CASE-REPORTS AND LITERATURE-REVIEW
    DONATH, EM
    HEITLAND, WU
    SCHINDLER, AE
    ARCHIVES OF GYNECOLOGY, 1986, 239 (02): : 115 - 122
  • [33] Prognostic value of high serum levels of CA-125 in malignant secretory peritoneal mesotheliomas affecting young women. A case report with differential diagnosis and review of the literature
    Bercero, EA
    Perez, GMGRY
    Bragado, FG
    Jimenez, C
    HISTOPATHOLOGY, 1997, 31 (03) : 267 - 273
  • [34] INDEPENDENT EXPRESSION IN SERUM OF 3 TUMOR-ASSOCIATED ANTIGENS - CA-125, PLACENTAL ALKALINE-PHOSPHATASE AND HMFG2 IN OVARIAN-CARCINOMA
    WARD, BG
    CRUICKSHANK, DJ
    TUCKER, DF
    LOVE, S
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (07): : 696 - 698
  • [35] A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
    Kristeleit, Rebecca
    Davidenko, Irina
    Shirinkin, Vadim
    El-Khouly, Fatima
    Bondarenko, Igor
    Goodheart, Michael J.
    Gorbunova, Vera
    Penning, Carol A.
    Shi, Jack G.
    Liu, Xiangdong
    Newton, Robert C.
    Zhao, Yufan
    Maleski, Janet
    Leopold, Lance
    Schilder, Russell J.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 484 - 490
  • [36] PRETREATMENT SERUM LEVELS OF CA-125, CARCINOEMBRYONIC ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN, AND PLACENTAL ALKALINE-PHOSPHATASE, IN PATIENTS WITH OVARIAN-CARCINOMA, BORDERLINE TUMORS, OR BENIGN ADNEXAL MASSES - RELEVANCE FOR DIFFERENTIAL-DIAGNOSIS
    THOLANDER, B
    TAUBE, A
    LINDGREN, A
    SJOBERG, O
    STENDAHL, U
    KIVIRANTA, A
    HALLMAN, K
    HOLM, L
    WEINER, E
    TAMSEN, L
    GYNECOLOGIC ONCOLOGY, 1990, 39 (01) : 16 - 25